Cart
sales@molnova.com
Home -
Products -
Others -
Other Targets -
Cyanidin-3-O-(6-O-trans-caffeyl-2-O-β-glucopyranosyl-β-glucopyranoside)-5-O-β-glucopyranoside
Cyanidin-3-O-(6-O-trans-caffeyl-2-O-β-glucopyranosyl-β-glucopyranoside)-5-O-β-glucopyranoside
CAS No. 185246-52-0
Cyanidin-3-O-(6-O-trans-caffeyl-2-O-β-glucopyranosyl-β-glucopyranoside)-5-O-β-glucopyranoside( ——— )
Catalog No. M39758 CAS No. 185246-52-0
Cyanidin-3-O-(6-O-trans-caffeyl-2-O-β-glucopyranosyl-β-glucopyranoside)-5-O-β-glucopyranoside
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCyanidin-3-O-(6-O-trans-caffeyl-2-O-β-glucopyranosyl-β-glucopyranoside)-5-O-β-glucopyranoside
-
NoteResearch use only, not for human use.
-
Brief DescriptionCyanidin-3-O-(6-O-trans-caffeyl-2-O-β-glucopyranosyl-β-glucopyranoside)-5-O-β-glucopyranoside
-
DescriptionCyanidin-3-O-(6-O-trans-caffeyl-2-O-β-glucopyranosyl-β-glucopyranoside)-5-O-β-glucopyranoside
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number185246-52-0
-
Formula Weight———
-
Molecular Formula———
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Norflurazon
Norflurazon is an excellent weed controlling agent being practiced in the agricultural lands.
-
Dazolicin HCl
Dazolicin HCl (Dazolicine HCl) is an orally available antiarrhythmic compound.
-
Siplizumab
Siplizumab (MEDI-507) is a humanized IgG1 monoclonal antibody that targets CD2, selectively depleting effector memory T cells and promoting the relative expansion of alloreactive regulatory T cells in vitro. Siplizumab can be used to treat plaque psoriasis.
